MedPath

Investigation of Analgesic and Anti-hyperalgesic Effect of Opioids in Experimental Pain

Phase 3
Completed
Conditions
Pain
Interventions
Registration Number
NCT00647127
Lead Sponsor
University of Aarhus
Brief Summary

To compare the analgesic and anti-hyperalgesic effect of Buprenorphine and Fentanyl against experimental pain in skin, muscle and bone. The study will be performed with healthy volunteers.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
22
Inclusion Criteria
  • written informed consent
  • men > 18 years
Exclusion Criteria
  • women
  • known allergy against the investigated drugs
  • ongoing participation in other experiments or participation in other experiments 14 days before screening
  • previously pain or psychiatric conditions
  • simultaneously use of pain killers
  • alcohol
  • previously drug-addict or member of family with drug-addicts
  • chronic constipation
  • ileus
  • inflammatory bowel syndrome
  • abdominal surgery within the last three months

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
FentanylFentanyl-
PlaceboPlacebo-
BuprenorphineBuprenorphine-
Primary Outcome Measures
NameTimeMethod
Data will be electronically recorded or written directly in case report form. Outcome measure will be a subjective rating of the pain with a visual analogue scale.Continuously
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mech Sense, Department of Gastroenterology

🇩🇰

Aalborg, Region Nordjyllan, Denmark

© Copyright 2025. All Rights Reserved by MedPath